Publication:
Predictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction

dc.contributor.authorÇETİN, MUSTAFA
dc.contributor.authorAkgul, Ozgur
dc.contributor.authorUyarel, Huseyin
dc.contributor.authorErgelen, Mehmet
dc.contributor.authorPusuroglu, Hamdi
dc.contributor.authorGul, Mehmet
dc.contributor.authorTuren, Selahattin
dc.contributor.authorBulut, Umit
dc.contributor.authorBaycan, Omer Faruk
dc.contributor.authorOzal, Ender
dc.contributor.authorYildirim, Aydin
dc.contributor.authorUslu, Nevzat
dc.date.accessioned2020-10-22T15:56:46Z
dc.date.available2020-10-22T15:56:46Z
dc.date.issued2013-10-01T00:00:00Z
dc.description.abstractObjectives: The prognostic value of cystatin C (CysC) has been documented in patients with acute coronary syndrome without ST-segment elevation. However, its value in acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the prognostic value of CysC in patients with STEMI undergoing primary percutaneous coronary intervention (PCI).
dc.identifier.citationAkgul O., Uyarel H., Ergelen M., Pusuroglu H., Gul M., Turen S., Bulut U., Baycan O. F. , Ozal E., ÇETİN M., et al., -Predictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction-, JOURNAL OF CRITICAL CARE, cilt.28, 2013
dc.identifier.doi10.1016/j.jcrc.2013.03.004
dc.identifier.scopus84883553475
dc.identifier.urihttp://hdl.handle.net/20.500.12645/23705
dc.identifier.wosWOS:000324374700059
dc.titlePredictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction
dc.typeArticle
dspace.entity.typePublication
local.avesis.id51fcdcb7-33d1-41f4-95ad-0e2242e845fe
local.publication.isinternational1
Files